These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. An overview of cholera vaccines and their public health implications. Desai SN, Clemens JD. Curr Opin Pediatr; 2012 Feb; 24(1):85-91. PubMed ID: 22157363 [Abstract] [Full Text] [Related]
25. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi. Msyamboza KP, M'bang'ombe M, Hausi H, Chijuwa A, Nkukumila V, Kubwalo HW, Desai S, Pezzoli L, Legros D. Pan Afr Med J; 2016 Feb; 23():203. PubMed ID: 27347292 [Abstract] [Full Text] [Related]
27. The case for ring vaccinations with special consideration of oral cholera vaccines. Deen J, von Seidlein L. Hum Vaccin Immunother; 2018 Feb; 14(8):2069-2074. PubMed ID: 29630444 [Abstract] [Full Text] [Related]
28. Considerations around the introduction of a cholera vaccine in Bangladesh. Nelson CB, Mogasale V, Bari TI, Clemens JD. Vaccine; 2014 Dec 12; 32(52):7033-6. PubMed ID: 24856784 [Abstract] [Full Text] [Related]
29. Introducing cholera vaccination in Asia, Africa and Haiti: a meeting report. Hall RH, Sack DA. Vaccine; 2015 Jan 15; 33(4):487-92. PubMed ID: 25437100 [Abstract] [Full Text] [Related]
31. Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014. Scobie HM, Phares CR, Wannemuehler KA, Nyangoma E, Taylor EM, Fulton A, Wongjindanon N, Aung NR, Travers P, Date K. PLoS Negl Trop Dis; 2016 Dec 15; 10(12):e0005210. PubMed ID: 27992609 [Abstract] [Full Text] [Related]
33. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011. Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V. Emerg Infect Dis; 2011 Nov 15; 17(11):2105-12. PubMed ID: 22099114 [Abstract] [Full Text] [Related]
34. Cholera vaccine will reduce antibiotic use. Okeke IN. Science; 2009 Aug 07; 325(5941):674. PubMed ID: 19661401 [No Abstract] [Full Text] [Related]
35. The true burden and risk of cholera: implications for prevention and control. Zuckerman JN, Rombo L, Fisch A. Lancet Infect Dis; 2007 Aug 07; 7(8):521-30. PubMed ID: 17584531 [Abstract] [Full Text] [Related]
36. Oral cholera vaccines and their impact on the global burden of disease. Wierzba TF. Hum Vaccin Immunother; 2019 Aug 07; 15(6):1294-1301. PubMed ID: 30183486 [Abstract] [Full Text] [Related]
37. Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study. Kim JH, Mogasale V, Burgess C, Wierzba TF. Vaccine; 2016 Apr 19; 34(18):2113-20. PubMed ID: 26993337 [Abstract] [Full Text] [Related]
38. Oral vaccines against cholera. Shin S, Desai SN, Sah BK, Clemens JD. Clin Infect Dis; 2011 Jun 19; 52(11):1343-9. PubMed ID: 21498389 [Abstract] [Full Text] [Related]